Brief: Ryvu Therapeutics Presents Updated Data On RVU120 At 2022 EHA Congress
10/06/2022 11:31
June 10 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* RYVU THERAPEUTICS PRESENTS UPDATED CLINICAL AND
PRECLINICAL DATA
ON RVU120 AT THE 2022 EUROPEAN HEMATOLOGY ASSOCIATION (EHA)
CONGRESS
Source text for Eikon: ID:nPn4tLPL8a
Further company coverage: RVU.WA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project